Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

av Shakeel Modak, Jean-Benoit Le Luduec, Irene Y. Cheung, Debra A. Goldman, Irina Ostrovnaya, Ekaterina Doubrovina, Ellen Basu, Brian H. Kushner, Kim Kramer, Stephen S. Roberts, Richard J. O'Reilly, Nai-Kong V. Cheung, Katharine C. Hsu
Publicerad 2018-08-01